Definium Therapeutics, Inc. (DFTX) Balance Sheet
As of 2026-06-30 (10-Q), Definium Therapeutics, Inc. (DFTX) reported total assets of $1.1B, total liabilities of $194.2M and shareholders' equity of $918.7M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $655.3M. Long-term debt: $36.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DFTXDefinium Therapeutics, Inc.Follow DFTX — free
—
Price chart with a free account
- Market cap
- 4.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.08 | 0.13 | 0.14 | 0.10 | 0.27 | 0.26 | 0.66 | |
| Short-term investments | — | — | — | — | 0.00 | 0.15 | 0.43 | |
| Current assets | 0.08 | 0.14 | 0.15 | 0.10 | 0.28 | 0.42 | 1.09 | |
| Total assets | 0.08 | 0.16 | 0.17 | 0.12 | 0.30 | 0.44 | 1.11 | |
| Current liabilities | 0.00 | 0.01 | 0.02 | 0.03 | 0.04 | 0.07 | 0.16 | |
| Long-term debt | — | — | — | 0.01 | 0.02 | 0.04 | 0.04 | |
| Total liabilities | 0.01 | 0.01 | 0.02 | 0.05 | 0.06 | 0.11 | 0.19 | |
| Shareholders' equity | 0.08 | 0.15 | 0.15 | 0.08 | 0.24 | 0.33 | 0.92 |
USD billions · SEC XBRL
Definium Therapeutics, Inc. — questions
- How much cash does Definium Therapeutics, Inc. have?
- $655.3M in cash and cash equivalents as of 2026-06-30.
- How much debt does Definium Therapeutics, Inc. have?
- $36.5M of long-term debt as of 2026-06-30.
- What are Definium Therapeutics, Inc.'s total assets?
- $1.1B as of 2026-06-30.
- What is Definium Therapeutics, Inc.'s shareholders' equity?
- $918.7M as of 2026-06-30.
Every figure on this page comes from Definium Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.